News

Lauren Taylor speaks to Dr Jack Mosley – son of the late Michael Mosley – about weight-loss medication. Dr Jack Mosley: ...
Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.
Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.
As multiple large drugmakers look to navigate trade turbulence by pumping billions of dollars into their U.S. | Eli Lilly CEO ...
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
In 2021, 529 million people were living with diabetes worldwide, and an estimated 1·31 billion individuals are projected to ...
The drug enhances outcomes in a high-risk patient population with a significant unmet need. Tirzepatide significantly ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...